EUROPLASMA: Statement of voting rights and shares as of September 30, 2026

EUROPLASMA, a prominent French company, has published its statement of voting rights and shares as of September 30, 2026. In accordance with the legislation governing the transparency of listed companies, the total number of shares and theoretical voting rights amounts to 2,547,110,468. Notably, these figures include both theoretical and exercisable voting rights, free from any restrictions due to treasury shares.

This crucial information for investors is part of a regulatory communication strategy. Europlasma, active since 1992 in sectors such as defense and waste treatment, is pursuing its strategy by distinguishing itself on the Euronext Growth market under the symbol ALEUP.